Probiotics for prevention and treatment of diarrhea

Journal of Clinical Gastroenterology

Volumn 49, Issue , 2015, Pages S37-S45

  Guarino, Alfredo ^a   Guandalini, Stefano ^b   Vecchio, Andrea Lo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antibiotic associated diarrhea; Children; Clostridium difficile; Diarrhea; Gastroenteritis; Necrotizing enterocolitis; Probiotics

Indexed keywords

PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ACUTE DIARRHEA; ACUTE GASTROENTERITIS; ADULT DISEASE; AGE DISTRIBUTION; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIACEAE; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG EFFICACY; HOSPITAL INFECTION; HUMAN; INFECTIOUS DIARRHEA; INTESTINE FLORA; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; NONHUMAN; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SACCHAROMYCES BOULARDII; ADULT; CHEMICALLY INDUCED; CHILD; ENTEROCOLITIS, NECROTIZING; GASTROENTERITIS; MICROBIOLOGY; NEWBORN; SACCHAROMYCES;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; DIARRHEA; ENTEROCOLITIS, NECROTIZING; GASTROENTERITIS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LACTOBACILLUS RHAMNOSUS; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SACCHAROMYCES;

EID: 84944210548     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000349     Document Type: Article

References (63)

1. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011;45(suppl):S149-S153.
2. Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidencebased guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59:132-152.
3. Guarino A, Canani RB, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr. 1997;25:516-519.
4. Karas J, Ashkenazi S, Guarino A, et al. on behalf of the Consensus Group on Outcome Measures Made in Paediatric Enteral Nutrition Clinical Trials (COMMENT). A core outcome set for clinical trials in acute diarrhoea. Arch Dis Child. 2015;100:359-363.
5. Saavedra JM, Tschernia A. Human studies with probiotics and prebiotics: clinical implications. Br J Nutr. 2002;87:241-246.
6. Saran S, Gopalan S, Krishna TP. Use of fermented foods to combat stunting and failure to thrive. Nutrition. 2002;18:393-396.
7. Szajewska H, Setty M, Mrukowicz J, et al. Probiotics in gastrointestinal disease in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006;42:454-475.
8. Gutierrez-Castrellon P, Lopez-Velazquez G, Diaz-Garcia L, et al. Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics. 2014;133:e904-e909.
9. Vandenplas Y, De Greef E, Hauser B, et al. Probiotics and prebiotics in pediatric diarrheal disorders. Expert Opin Pharmacother. 2013;14:397-409.
10. Braegger C, Chmielewska A, Decsi T, et al. ESPGHAN Committee on Nutrition. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238-250.
11. Thomas DW, Greer FR. Clinical report: probiotics and prebiotics in pediatrics. Pediatrics. 2010;126:1217-1231.
12. World Health Organisation/Patient Safety. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. Geneva, Switzerland: World Health Organization; 2011.
13. Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect Dis. 2008;8:19-31.
14. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther. 2011;34:1079-1087.
15. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of a health claim related to Lactobacillus rhamnosus GG and maintenance of defence against pathogenic gastrointestinal microorganisms pursuant to Article 13 (5) of Regulation (EC) No 1924/2006. EFSA J. 2011;9:2167.
16. Wada M, Nagata S, Saito M, et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Supp Care Cancer. 2010;18:751-759.
17. Szajewska H, Wanke M. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2012;161:40-43.
18. Acute Gastroenteritis Guideline Team, Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for prevention and management of acute gastroenteritis in children age 2 months to 18 years. Available at: http://www.guideline. gov/content.aspx?id=35123&search=cincinnati+and+% 28gastroenteritis+or+diarrhea%29. Accessed December 21, 2011.
19. College of paediatrics, Academy of medicine of Malaysia, Malaysian paediatric association. The management of acute diarrhoea in children 2011. Available at: http://acadmed.org.my/index.cfm?&menuid=83&parentid=34. Accessed March 4, 2015.
20. Salazar-Lindo E, Polanco Allué I, Gutiérrez-Castrellón P. Ibero-Latin American Clinical Practice. Guidelines for the management of gastroenteritis for children below 5 years of age: pharmacological treatment. An Pediatr (Barc). 2014;80(suppl 1):15-22.
21. Harris C, Wilkinson F, Mazza D, et al. Evidence based guidelines for the management of diarrhea with or without vomiting in children. Aust Fam Physician. 2008;37:22-29.
22. Wittenberg DF. Management guidelines for acute infective diarrhoea/gastroenteritis in infants. S Afr Med J. 2012;102:104-107.
23. Ministry of public health and sanitation. Policy Guidelines on Control and Management of Diarrhoeal Diseases in Children Below Five Years in Kenyar. 2013 Available at: www.publichealth.go.ke.
24. National Institute for Health and Clinical Excellence. Diarrhoea and vomiting in children: Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment and management in children younger than 5 years. Guidelines CG84; 2009. Available at: https://www.nice.org.uk/guidance/cg84.
25. Bhatnagar S, Lodha R, Choudhury P, et al. IAP guidelines 2006 on management of acute diarrhea. Indian Pediatr. 2007;44:380-389.
26. King CK, Glass R, Bresee JS, et al. Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.
27. Szajewska H, Guarino A, Hojsak I, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2014;58:531-539.
28. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74:6032-6040.
29. Szajewska H, Skorka A, Ruszczynski M, et al. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther. 2013;38:467-476.
30. Fang SB, Lee HC, Hu JJ, et al. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J Trop Pediatr. 2009;55:297-301.
31. Schutze GE, Willoughby RE. Committee on Infectious Diseases; American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics. 2013;131:196-200.
32. Lo Vecchio A, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol. 2012;28:1-9.
33. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.
34. Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibioticassociated diarrhoea. Aliment Pharmacol Ther. 2012;35:1355-1369.
35. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959-1969.
36. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2011;11:CD004827.
37. Pant C, Deshpande A, Altaf MA, et al. Clostridium difficile infection in children: a compre-hensive review. Curr Med Res Opin. 2013;29:967-984.
38. Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31:1012-1017.
39. McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe. 2009;15:274-280.
40. Gao XV, Mubasher M, Fang CY, et al. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibioticassociated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105:1636-1641.
41. Pillai A, Nelson RL. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev. 2008;1:CD004611.
42. Ooi CY, Dilley AV, Day AS. Saccharomyces boulardii in a child with recurrent Clostridium difficile. Pediatr Int. 2009;51:156-158.
43. Na JY, Park JM, Lee KS, et al. Clinical characteristics of symptomatic Clostridium difficile infection in children: conditions as infection risks and whether probiotics is effective. Pediatr Gastroenterol Hepatol Nutr. 2014;17:232-238.
44. Na X, Kelly C. Probiotics in Clostridium difficile infection. J Clin Gastroenterol. 2011;45(suppl):S154-S158.
45. Walia R, Garg S, Song Y. Efficacy of fecal microbiotia transplantation in 2 children with recurrent Clostridium difficile nfection and its impact on their growth and gut microbiome. J Pediatr Gastroenterol Nutr. 2014;59:565-570.
46. Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2010;44:354-360.
47. Russell G, Kaplan J, Ferraro M, et al. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics. 2010;126:e239-e242.
48. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health. 2014;9:584-671.
49. Cochrane Database Syst Rev. 2014;4:CD005496.
50. Bernardo WM, Aires FT, Carneiro RM, et al. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J Pediatr (Rio J). 2013;89:18-24.
51. Jacobs SE, Tobin JM, Opie GF, et al. Probiotic effects on lateonset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132:1055-1062.
52. Mihatsch WA, Braegger CP, Decsi T, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr. 2012;31:6-15.
53. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very lowbirthweight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg. 2012;47:241-248.
54. Sari FN, Dizdar EA, Oguz S, et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr. 2011;65:434-439.
55. Braga TD, da Silva GA, de Lira PI, et al. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93:81-86.
56. Deshpande G, Rao S, Patole S, et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125:921-930.
57. Fallon EM, Nehra D, Potemkin AK, et al. American Society for Parenteral and Enteral Nutrition (A. S. P. E. N.). Board of Directors, Puder M. A. S. P. E. N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2012;36:506-523.
58. Downard CD, Renaud E St, Peter SD, et al. 2012 American Pediatric Surgical Association Outcomes Clinical Trials Committee. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2012;47:2111-2122.
59. Agostoni C, Buonocore G, Carnielli VP, et al. ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010;50:85-91.
60. Necrotizing Enterocolitis (NEC) Guideline Team. Cincinnati Children's Hospital Medical Center: evidence-based care guideline for necrotizing enterocolitis among very low birth weight infants. Pediatric Evidence-Based Care Guidelines, Cincinnati Children's Hospital Medical Center Guideline 2010;28:1-10.
61. Bonsante F, Iacobelli S, Gouyon JB. Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol. 2013;30:41-46.
62. Metchnikoff E. Optimistic studies. New York: Putman's Sons; 1908:161-183.
63. Anukam KC, Reid G. Probiotics: 100 years (1907-2007) After Elie Metchnikoff's observations. In: Mendez-Vilas A, ed, Communicating Current Research and Educational Topics and Trends in Applied Microbiology. Spain: Formatex.org; 2007:466-474.